Michael E. Abram

Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication

Michael E. Abram, Andrea L. Ferris, Wei Shao et al. · Journal of Virology · 2010 · 276 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 215 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment

Anton Pozniak, José Ramón Arribas, Joseph Gathe et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 184 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial

Joel E. Gallant, Eric S. Daar, François Raffi et al. · The Lancet HIV · 2016 · 165 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences

Áine O’Toole, Oliver G. Pybus, Michael E. Abram et al. · BMC Genomics · 2022 · 145 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17